عنوان
پدید آورنده
موضوع
رده
کتابخانه
محل استقرار
NATIONAL BIBLIOGRAPHY NUMBER
Number
LA7rn5d6mp
LANGUAGE OF THE ITEM
.Language of Text, Soundtrack etc
انگلیسی
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Sorafenib Induced Eruptive Melanocytic Lesions
General Material Designation
[Article]
First Statement of Responsibility
Uhlenhake, Elizabeth E.; Watson, Alice C.; Aronson, Peter
SUMMARY OR ABSTRACT
Text of Note
Sorafenib is a multikinase inhibitor FDA-approved for the treatment of advanced renal cell and hepatocellular carcinoma. Dermatologic side effects include hand-foot skin reaction, facial and scalp erythema and desquamation, splinter subungual hemorrhages, alopecia, pruritus, xerosis, keratoacanthomas, and squamous cell carcinomas. We report sudden eruption of melanocytic nevi diffusely in a patient receiving sorafenib.
SET
Date of Publication
2013
Title
Dermatology Online Journal
Volume Number
19/5
PERSONAL NAME - PRIMARY RESPONSIBILITY
Entry Element
Uhlenhake, Elizabeth E.; Watson, Alice C.; Aronson, Peter
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Article]
275578
a
Y
